Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Gene therapy for autoimmune disease.

C G Fathman¹, G L Costa, C M Seroogy

¹Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, California 94305-5111, USA.

Clinical Immunology (Orlando, Fla.)

|March 24, 2000

Summary

Autoantigen-specific CD4(+) T cells can be engineered using retroviral transduction. This approach offers a targeted gene therapy strategy for autoimmune diseases by isolating these rare cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reply to Arnemo and Kreeger: "Commentary on 'Influence of Ambient Temperature and Confinement on the Chemical Immobilization of Fallow Deer ( Dama dama )'".

Journal of wildlife diseases·2017

Same author

Human eosinophils release IL-1ß and increase expression of IL-17A in activated CD4+ T lymphocytes.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012

Same author

An optimized multi-parameter flow cytometry protocol for human T regulatory cell analysis on fresh and viably frozen cells, correlation with epigenetic analysis, and comparison of cord and adult blood.

Journal of immunological methods·2012

Same author

Dengue-2 structural proteins associate with human proteins to produce a coagulation and innate immune response biased interactome.

BMC infectious diseases·2011

Same author

Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25- T cells with anergic and suppressive genetic signatures.

Clinical and experimental immunology·2008

Same author

Synaptic contacts impaired by styrene-7,8-oxide toxicity.

Toxicology and applied pharmacology·2007

Area of Science:

Immunology
Gene Therapy
Autoimmune Diseases

Background:

Autoimmune diseases involve CD4(+) T lymphocytes targeting self-antigens.
Tissue-specific homing of these T cells suggests therapeutic potential.
Targeting rare, antigen-activated T cells is crucial for effective gene therapy.

Purpose of the Study:

To explore retroviral transduction of autoantigen-specific CD4(+) T cells.
To develop a method for targeting and isolating these specific T cells.
To establish a rational gene therapy approach for animal models of autoimmunity.

Main Methods:

Retroviral transduction of autoantigen-specific murine CD4(+) T cells.
Isolation of non-transformed, antigen-specific T cells.

Related Experiment Videos

Application in animal models of autoimmune diseases.

Main Results:

Retroviral transduction successfully targeted autoantigen-specific CD4(+) T cells.
The method allowed for the isolation of rare, antigen-activated T cells.
This approach shows promise for gene therapy in autoimmunity.

Conclusions:

Retroviral transduction of autoantigen-specific CD4(+) T cells is a viable strategy.
This method provides a rational approach for gene therapy in autoimmune disease models.
Further research can advance site-specific delivery of therapeutic proteins.